| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial MD Tameris, M Hatherill, BS Landry, TJ Scriba, MA Snowden, S Lockhart, ... The Lancet 381 (9871), 1021-1028, 2013 | 1181 | 2013 |
| Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant V Shinde, S Bhikha, Z Hoosain, M Archary, Q Bhorat, L Fairlie, U Lalloo, ... New England Journal of Medicine 384 (20), 1899-1909, 2021 | 672 | 2021 |
| Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ... New England Journal of Medicine 381 (25), 2429-2439, 2019 | 427 | 2019 |
| Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ... New England Journal of Medicine 379 (17), 1621-1634, 2018 | 376 | 2018 |
| The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults B Abel, M Tameris, N Mansoor, S Gelderbloem, J Hughes, D Abrahams, ... American journal of respiratory and critical care medicine 181 (12), 1407-1417, 2010 | 317 | 2010 |
| T-cell activation is an immune correlate of risk in BCG vaccinated infants HA Fletcher, MA Snowden, B Landry, W Rida, I Satti, SA Harris, ... Nature communications 7 (1), 11290, 2016 | 290 | 2016 |
| Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells TJ Scriba, M Tameris, N Mansoor, E Smit, L van der Merwe, F Isaacs, ... European journal of immunology 40 (1), 279-290, 2010 | 256 | 2010 |
| Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa T Hawkridge, TJ Scriba, S Gelderbloem, E Smit, M Tameris, S Moyo, ... The Journal of infectious diseases 198 (4), 544-552, 2008 | 220 | 2008 |
| First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults AKK Luabeya, BMN Kagina, MD Tameris, H Geldenhuys, ST Hoff, Z Shi, ... Vaccine 33 (33), 4130-4140, 2015 | 208 | 2015 |
| Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase … A Penn-Nicholson, M Tameris, E Smit, TA Day, M Musvosvi, ... The Lancet Respiratory Medicine 6 (4), 287-298, 2018 | 143 | 2018 |
| Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults CL Day, M Tameris, N Mansoor, M van Rooyen, M de Kock, ... American journal of respiratory and critical care medicine 188 (4), 492-502, 2013 | 142 | 2013 |
| Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? M Hatherill, T Hawkridge, HJ Zar, A Whitelaw, M Tameris, L Workman, ... Archives of disease in childhood 94 (3), 195-201, 2009 | 142 | 2009 |
| Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study JR Andrews, E Nemes, M Tameris, BS Landry, H Mahomed, JB McClain, ... The lancet Respiratory medicine 5 (4), 282-290, 2017 | 135 | 2017 |
| Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting A Penn-Nicholson, H Geldenhuys, W Burny, R van der Most, CL Day, ... Vaccine 33 (32), 4025-4034, 2015 | 123 | 2015 |
| Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial M Tameris, H Mearns, A Penn-Nicholson, Y Gregg, N Bilek, S Mabwe, ... The lancet Respiratory medicine 7 (9), 757-770, 2019 | 117 | 2019 |
| Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants TJ Scriba, M Tameris, N Mansoor, E Smit, L van der Merwe, K Mauff, ... Journal of Infectious Diseases 203 (12), 1832-1843, 2011 | 117 | 2011 |
| A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis–infected Adults TJ Scriba, M Tameris, E Smit, L van der Merwe, EJ Hughes, B Kadira, ... American journal of respiratory and critical care medicine 185 (7), 769-778, 2012 | 112 | 2012 |
| HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine N Mansoor, TJ Scriba, M de Kock, M Tameris, B Abel, A Keyser, F Little, ... The Journal of infectious diseases 199 (7), 982-990, 2009 | 112 | 2009 |
| The candidate TB vaccine, MVA85A, induces highly durable Th1 responses M Tameris, H Geldenhuys, AKK Luabeya, E Smit, JE Hughes, S Vermaak, ... PloS one 9 (2), e87340, 2014 | 111 | 2014 |
| Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ... The Lancet Infectious Diseases 21 (3), 354-365, 2021 | 106 | 2021 |
